Abstract
The majority of the compounds to be discussed in this chapter are either aromatic or heterocyclic in structure. Aliphatic compounds have been described previously in Volume XX/1 of this Handbuch, e.g. by Metcalf (insecticides), Pattison and Peters (monofluoro aliphatic compounds), Clayton (fluoroalkanes, fluoroalkenes, and fluoroalcohols), and Krantz and Rudo (anesthetics). Certain other classes are discussed elsewhere in this volume (Chen, Jr. and Borrevang, steroids; Marquis, arnino acids).
The author appreciates the time and effort given by Dr. Harold C. Hodge and Dr. Paul E. Morrow in reading and commenting upon the manuscript of this chapter. He also expresses his thanks to Mr. W.L. Downs and to Drs. A.L. Dounce, R.W. Helmkamp and E.R.M. Kay for a number of beneficial discussions of certain of the topics presented. Dr. Helmkamp was especially helpful in questions of organic chemical nomenclature.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abell, C. W., Heidelberger, C.: Interaction of carcinogenic hydrocarbons with tissues. VIII. Binding of tritium labeled hydrocarbons to the soluble proteins of mouse skin. Cancer Res. 22, 931–945 (1962)
Ali, D.A., Callely, A.G., Hayes, M.: Ability of a Vibrio grown on benzoate to oxidize parafluorobenzoate. Nature (Lond.) 196, 194–195 (1962)
Alphin, R.J., Funderbunk, R.H., Ward, J.W.: Anorexigenic activity of N-ethyl-a-methyl-3-trifluoromethylphenethylamine hydrochloride (AHR-965), a non-CNS stimulant. Toxicol. appl. Pharmacol. 6, 340 (1964)
van Andel, O.M.: Fluorophenylalanine as a systemic fungicide. Nature (Lond.) 194, 790 (1962)
Andén, N.-E., Dahlström, A., Fuxe, K., Hokfelt, T.: The effect of haloperidol and chlorpromazine on the amine labels of central monoamine neurons. Acta physiol. scand. 68, 419–420 (1966)
Andén, N.-E., Roos, B.-E., Werdinius, B.: Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acid in rabbit corpus striatum. Life Sci. 3, 149–158 (1964)
Anderson, B. R., McLane, R.: Control of annual bluegrass and crab grass in turf with fluorophenoxyacetic acids. Weeds 6, 52–58 (1958)
Anderson, F.E., Kaminsky, D., Dubrick, B., Klutchko, S.R., Cetenko, W.A., Gylys, J., Hart, J.A.: Chemistry and pharmacology of monoamine oxidase inhibitors: hydrazine derivatives. J. med. pharm. Chern. 5, 221–230 (1962)
Arcos, J.C., Simon, J.: Effect of 4’substituents on the carcinogenic activity of 4-aminoazobenzene derivatives. Arzneimittel-Forsch. 12, 270–275 (1962)
Armstrong, M.D., Lewis, J.D.: The toxicity of 0- and p-fluorophenyl-DL-alaninesfor the rat. J. bioI. Chern. 188, 91–95 (1951a)
Armstrong, M.D., Lewis, J.D. Effect of phenylalanine on the toxicity of 4-fluorophenylalanine for the rat. J. biol. Chern. 190,461–466 (1951b)
Astwood, E.B., Bissel, A., Hughes, A.M.: Further studies on the chemical nature of compounds which inhibit the function of the thyroid gland. Endocrinology 37,456–481 (1945)
Augstein, J., Austin, W.C., BosCott, R.J., Green, S.M., Wortffing, C.R.: Some cardiovascular effects of a series of aryloxyalkylamines. I. J. med. Chern. 8, 356–367 (1965)
Azouz, W.M., Parke, D.V., Williams, R.T.: Studies in detoxication. 42. Fluorobenzene. Spectrophotometric determination of the elimination of unchanged halogenobenzenes by rabbits. A comparison of the oxidation in vivo of fluorobenzene and of benzene. Biochem. J. 50, 702–706 (1952)
Azouz, W.M., Parke, D.V., Williams, R.T. Studies in detoxication. 51. The determination of catechols in urine, and the formation of catechols in rabbits receiving halogenobenzenes and other compounds. Dihydroxylation in vivo. Biochem. J. 55, 146–151 (1953)
Baer, J.E., Seidy, H.L., Brooks, A.V., Beyer, K.H.: The physiological disposition of chlorothiazide (diuril) in the dog. J. Pharmacol. expo Ther. 125,295–302 (1959)
Baldwin, R. W., Cunningham, G.J., Dean, H. G., Partridge, M. W., Surtees, J.J., Vipond, H. J.: Further studies on the influence of peripheral ring substitution on the carcinogenicity of tricycloquinazoline. Biochem. Pharmacol. 14, 323–331 (1965)
Baldwin, R. W., Cunningham, G.J., Partridge, M. W., Vipond, H.J.: Studies on the carcinogenicity oftricycloquinazoline. The effect of substitution in the peripheral carbocyclic rings on carcinogenic activity. Brit. J. Cancer 16, 275–282 (1962)
Banks, R.E., Goldwhite, H.: Fluorine Chemistry. In: F.A. Smith (Ed.), Handbuch der experimentellen Pharmakologie XX/I, 1–52. Berlin-Heidelberg-New York: Springer 1966
Barker, S.B., Dirks, H.B., JR., Garlick, W.R., Klitgaard, H.M.: Further studies on antithyroxine effects of various compounds. Proc. Soc. expo BioI. Med. (N.Y.) 78, 840–845 (1952)
Barnett, J.E.G., Jarvis, W. T.S., Munday, K.A.: Enzymic hydrolysis of the carbonfluorine bond of a-D-glucosyl fluoride by rat intestinal mucosa. Localization of intestinal maltase. Biochem. J. 103, 699–704 (1967a)
Barnett, J.E.G., Jarvis, W. T.S., Munday, K.A. The hydrolysis of glucosyl fluorides by glycosidases. Biochem. J. 105, 669–672 (1967b)
Barone, J.A., Tieckelmann, H., Guthrie, R., Holland, J.F.: A 2-trifluoromethyl analog ofthiamin. J. Org. Chern. 25, 211–213 (1960)
Barron, D.I., Bavin, P.M.G., Durant, G.J., Natoff, I.L., Spickett, R.G.W., Vallance, D.K.: Potential hypertensive agents. Some guanidine derivatives. J. med. Chern. 6, 705–711 (1963)
Beaver, D.J., Roman, D.P., Stoffel, P.J.: The preparation and bacteriostatic activity of halogenated carbanilates. J. med. Chern. 6, 501–506 (1963)
Beckett, A.H., Brookes, L.G.: The absorption and urinary excretion in man of fenfluramine and its main metabolite. J. Pharm. Pharmacol. 19, Suppl., 42S–49S (1967)
Behrens, O.K., Corse, J., Edwards, J.P., Garrison, L., Jones, R.G., Soper, Q.F., van Abeele, Whitehead, C. W.: Biosynthesis of penicillins. IV. New crystalline biosynthetic penicillins. J. biol. Chern. 175,793–809 (1948b)
Behrens, O.K., Corse, J., Huff, D.E., Jones, R.G., Soper, Q.F., Whitehead, C.W.: Biosynthesis of penicillins. III. Preparation and evaluation of precursors for new penicillins. J. biol. Chern. 175, 771–792 (1948a)
Behrens, O.K., Kingkade, M. J.: Biosynthesis of penicillins. VIII. Studies with new biosynthetic penicillins on penicillin resistance. J. biol. Chern. 176, 1047–1050 (1948)
Behrman, E. J., Stanier, R. Y.: The bacterial oxidation of nicotinic acid. J. bioI. Chern. 228, 923–945 (1957a)
Behrman, E. J., Stanier, R. Y. Observations on the oxidation of halogenated nicotinic acids. J. biol. Chern. 228, 947–953 (1957b)
Belleau, B.: The mechanism of drug action at receptor surfaces. Part I. Introduction. A general interpretation of the adrenergic blocking activity of.B-haloalkylamines. Canad. J. Biochem. 36, 731–753 (1958)
Ben-David, M., Dirkstein, S., Suhman, F.G.: Production of lactation by non-sedative phenothiazine derivatives. Proc. Soc. expo BioI. Med. (N.Y.) 118, 265–270 (1965)
Benington, F., Morin, R.D., Clark, J.C., Jr., Fox, R.P.: Psychopharmacological activity of ring- and side chain-substituted.β-phenethylamines. J. Org. Chern. 23, 1979–1984 (1958)
Bergmann, E.D.: Synthetic and biochemical studies on organic fluorine compounds. Bull. Res. Coun. Israel E 10A, 1–16 (1961)
Bernheim, F.: The oxidative desulfuration of thio-acids. Biochem. biophys. Acta (Arnst.) 90, 426–428 (1964)
Beyer, K.H.: The mechanism of action of chlorothiazide. Ann. N.Y. Acad. Sci. 71, 363–379 (1958)
Beyer, K.H., Baer, J.E.: The pharmacology of chlorothiazide and its analogues. Int. Rec. Med. 172, 413–426 (1959)
Beyer, K.H., Baer, J.E. Physiological basis for the action of newer diuretic agents. Pharmacol. Rev. 13, 517–562 (1961)
Bickel, M. H., Sulser, F., Brodie, B. B.: Conversion of tranquilizers to anti-depressants by removal of one N-methyl group. Life Sci. 2, 247–253 (1963)
Biel, J.H., Drukker, A.E., Mitchell, T.F., Sprengler, E.P., Nuhfer, P.A., Conway, A. C., Horita, A.: Central stimulants. Chemistry and structure-activity relationships of aralkyl hydrazines. J. Amer. chern. Soc. 81, 2805–2813 (1959)
Biel, J.H., Nuhfer, P.A., Drukker, A.E., Mitchell, T.F., Conway, A.C., Horita, A.: A new class of potent monoamine oxidase inhibitors. Chemistry and structure-activity relationships of aminoalkylhydrazines. J. Org. Chern. 26,3338–3341 (1961)
Bierbaum, B.A., Traverso, J.J., Whitehead, C.W.: Hypotensive 1,2,4-benzothiadiazines. J. med. Chem. 6, 272–275 (1963)
Bishop, B. C., Chelton, E. T.J., Jones, A. S.: The antibacterial activity of some fluorine-containing benzimidazoles. Biochem. Pharmacol. 13, 751–754 (1964)
Blackmore, W.F.: Failure of benzydroflumethiazide and hydrochlorothiazide to influence plasma potassium in nephrectomized dogs. Proc. Soc. expo Biol. Med. (N.Y.) 106, 681–683 (1961)
Blake, D.A., Rozman, R.S., Cascorbi, H.F., Krantz, J.C., Jr.: Anesthesia LXXIV: Biotransformation of fluroxene. I. Metabolism in mice and dogs in vivo. Biochem. Pharmacol. 16, 1237–1248 (1967)
Blank, B., Farina, F.A., Kerwin, J.F., Saunders, H.: The synthesis of some potential hypoglycemic agents. J. Org. Chem. 26, 1551–1553 (1961)
Borhani, N. O.: The use of chlorothiazide and other thiazide derivatives in the treatment of hypertension. Int. Rec. Med. 172, 509–516 (1959)
Borsook, H., Fischer, E.H., Keighley, G.: Factors affecting protein synthesis in vitro in rabbit reticulocytes. J. biol. Chem. 229, 1059–1070 (1957)
Bowman, W.H., Mallette, M.F.: Catabolism of p-fluorophenylalanine by Escherichia coli. Arch. Biochem. 117, 563–572 (1966)
Boyer, P.D., Evans, R.J., Pidllips, P.H.: The toxicity and effect of certain fluorinated derivatives of phenylalanine and tyrosine on the basal metabolic rate of the rat. J. Pharmacol. expo Therff. 72, 176–185 (1941)
Boyland, E., Sims, P.: Metabolism of polycyclic compounds. 12. An acid-labile precursor of I-naphthylmercapturic acid and naphthol: an N-acetyl-S-(I: 2-dihydrohydroxynaphthyl)L-cysteine. Biochem. J. 68, 440–447 (1958)
Braun, G.A., Poos, G.I., Soudijn, W.: Distribution, excretion and metabolism ofneuroleptics of the butyrophenone type. Part II. Distribution, excretion and metabolism of haloperidol in Sprague-Dawley rats. Europ. J. Pharmacol. 1, 58–62 (1967)
Bray, H.G., Clowes, R.C., Thorpe, W.V., White, K., Wood, P.B.: The fate of certain organic acids and amides in the rabbit. 13. Chloro- and fluorobenzoic acids and amides. Biochem. J. 50, 583–587 (1952)
Bray, H.G., James, S. P., Thorpe, ‘V. V.: Metabolism of o-, m- and p-fluoro-, bromo- and -iodo-nitrobenzenes in the rabbit. Biochem. J. 68, 561–568 (1958)
Bray, H.G., James S.P., Thorpe, W.Y., Wasdell, M.R.: The fate of certain organic acids and amides in the rabbit. 11. Further observations on the hydrolysis of amides by tissue extracts. Biochem. J. 47, 294–299 (1950)
Brown, F.C., Harris, C.M., Perry, F.: 5-Isonitrosorhodanines. J. med. pharm. Chem. 5, 1239–1243 (1962)
Brunt, R.Y., Taylor, N.F.: The metabolism of 3-deoxy-3-fluoro-D-glucose by Saccharomyces cerevisiae. Biochem. J. 105, 41C–43C (1967)
Buchanan, R.L., Dean, F.H., Pattison, F.L.M.: γ-Fluoroglutamic acid. Canad. J. Chem. 40, 1571–1575 (1962)
Bunnett, J. F., Zahler, R. E.: Aromatic nucleophilic substitution reactions. Chem. Rev. 49, 273–412 (1951)
Burkhard, W.P., Gey, K.F., Pletscher, A.: Neuroleptica als Aktivatoren der Tyrosinhydroxylierung in vivo. Helv. physiol. pharmacol. Acta 24, 678–680 (1966)
Burton, D.E., Lambie, A.J., Ludgate, J.C.L., Newbold, G. T., Percival, A., Saggers, T.: 2-Trifluoromethylbenzimidazoles: a new class of herbicidal compounds. Nature (Lond.) 208, 1166–1169 (1965)
Busch, H., Olle, E.W., Abrams, D.L.: Selective inhibition of glycolysis in slices of neoplastic tissues by fluoropyruvic acid. Fed. Proc. 16, 286–287 (1957)
Buu-Hoï, N.P.: Les dérivés organiques du fluor d’intérêt pharmacologique. In: E. Jucker (Ed.), Progress in Drug Research, vol. 3, pp. 9–74. New York, N.Y.: Interscience Publishers, Inc. (1961)
Buu-Hoï, N.P. Fluorotoxicosis and fluoridotoxicosis. In: T. Gordonoff (Ed.), The Toxicology of Fluorine, pp. 9–13. Basel, Switzerland: Schwabe and Co. (1964a)
Buu-Hoï, N.P. New developments in chemical carcinogenesis by polycyclic hydrocarbons and related heterocycles: a review. Cancer Res. 24, 1511–1523 (1964b)
Buu-Hoï, N.P., Xuong, N.D., Tien, N.B., Gazave, J.M., Pillot, J., Dufraisse, G.: Sur l’activite tuberculostatique des N-arylgycines para-substituees. Experientia (Basel) 13, 235–236 (1957)
Cain, R.B., Tranter, E.K., Darrah, J.A.: The utilization of some halogenated aromatic acids by Nocardia. Oxidation and metabolism. Biochem. J. 106,211–227 (1968)
Callely, A.G., Jones, J.G.: The ability of the monofluorobenzoates to act as inducers of benzoate oxidation in Vibrio 01. Biochem. J. 97, 116–126 (1965)
Campbell, K.N.: Phenothiazine derivatives in urine: “False negative results” with the Forrest color test (FPN), and a method for their elimination. Clin. Chem. 11, 914–919 (1965)
Carlsson, A., Lindquist, M.: Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta pharmacol. (Kbh.) 20, 140–144 (1963)
Casida, J. E.: Toxicity of aromatic acids to the larvae of the mosquito Aedes aegypti L. and the counteracting influence of amino acids. Biochem. J. 59, 216–221 (1955)
Casterra, H.: Experiences with a new organic fluorine preparation in cases of hyperthyreosis. Letter to the Editor. Dtsch. Gesundh.-Wes. 2, 704–705 (1947)
Chalvet, O., Mason, R.: Carcinogenicity of the methyl-l,2-benzanthracenes and their derivatives. Nature (Lond.) 192, 1070–1072 (1961)
Chapman, N.B., James, J. W., Graham, J.D.P., Lewis, G.P.: Chemical reactivity and pharmacological activity among 2-haloethylamine derivatives with a naphthylmethyl group. Chem. Ind., 16th Aug., pp. 805–807 (1952)
Cheng, J. Y. O., Yu, M.H., Miller, G. W., Welkie, G. W.: Fluoroorganic acids in soybean leaves exposed to fluoride. Environ. Sci. Technol. 2, 367–370 (1968)
Chenoweth, M. B., McCarty, L. P.: On the mechanisms of the pharmacophoric effect of halogenation. Pharmacol. Rev. 15, 673–707 (1963)
Chirigos, M.A., Fanning, G.R., Guroff, G.: Effects of amino acids, analogs, and certain other agents in relation to tyrosine transport in Sarcoma 37 ascites cells. Cancer Res. 22, 1349–1355 (1962)
Chirigos, M.A., Greengard, P., Udenfriend, S.: Uptake of tyrosine by rat brain in vivo. J. biol. Chem. 235, 2075–2079 (1960)
Christensen, J.A., Hernestam, S., Lassen, J.B., Sterner, N.: Pharmacological and toxicological studies on γ-(4-methylpiperidino)-p-fluorobutyrophenone (FG5111) – a new neuroleptic agent. Acta pharmacol. (Kbh.) 23, 109–132 (1965)
Clarke, H.T., Johnson, J.R., Robinson, R.: The Chemistry of Penicillin. Princeton, N.J.: Princeton University Press 1949
Clayton, J. W., Jr.: The mammalian toxicology of organic compounds containing fluorine. In: Frank A. Smith (Ed.), Handbuch der experimentellen Pharmakologie, XX/I, 459–500. Berlin-Heidelberg-New York: Springer 1966
Cohen, A.J., Smith, J.N.: Comparative detoxication. 9. The metabolism of some halogenated compounds by conjugation with glutathione in the locust. Biochem. J. 90, 449–456 (1964)
Coppola, F. L.: The transformation of fluorobenzoic acids in the animal organism. Gazz. chim. ital. 13, 521–525 (1883)
Corse, J.W., Jones, R.G., Soper, Q.F., Whitehead, C. W., Behrens, O.K.: Biosynthesis of penicillins. V. Substituted phenylacetic acid derivatives as penicillin precursors. J. Amer. chem. Soc. 70, 2837–2843 (1948)
Cortell, R. E.: The antithyroxine activity of throxine analogs. J. elin. Endocr. 9, 955–966 (1949)
Cragoe E. J., Jr., Woltersdorf, O. W., Jr., Baer, J. E., Sprague, J. M.: Synthesis and diuretic activity of 3,3-spiro-substituted hydrothiazides. J. med. pharm. Chem. 5, 896–912 (1962)
Cuong, D.Q., Buu-Hoï, N.P., Xuong, N.D.: The synthesis of halogenated tuberculostatic thiocarbanilides. J. med. Chem. 6,452–455 (1963)
Daly, J. W., Guroff, G., Udenfriend, S., Witkop, B.: Hydroxylation of alkyl and halogen substituted anilines and acetanilides by microsomal hydroxylases. Biochem. Pharmacol. 17, 31–36 (1968)
Davies, J.I., Evans, W.C.: The elimination of halide ions from aliphatic halogen-substituted organic acids by an enzyme preparation from Pseudomonas dehalogenans. Biochem. J. 82, 50P–51P (1962)
Davis, P. W., Brody, T. M.: Inhibition of N a + -K + -activated adenosine triphosphatase activity in rat brain by substituted phenothiazines. Biochem. Pharmacol. 15, 703–710 (1966)
Delbarre, F., Richet, F.G., Buu-Hoï, N.P., Jacqidgnon, P., Perin, F.: On some biologic properties of a fluorinated analog of triparanol. Med. expo (Basel) 5,437–441 (1961)
Dietrich, L. S., Shapmo, D. M.: Fluoroacetate and fluorocitrate antagonism of tumor growth. Effect of these compounds on citrate metabolism in normal and neoplastic tissue. Cancer Res. 16, 585–588 (1956)
Discher, C.A., Cross, J.M., Smith, P.F., Iannarone, M.: The synthesis and antifungal properties of 6-fluorothymol. J. Amer. pharm. Ass., sci. Ed. 67, 689–691 (1958)
Dolan, G., Godin, C.: In vivo formation oftyorosine from p-luorophenylalanine. Biochem. J. 5, 922–925 (1966)
Dolan, M. M., Bondi, A., Hoover, J. R. E., Tumilowicz, R., Stewart, R. C., Ferlanto, R. J.: In: M. Finland and G.M. Savage (Eds.), Antimicrobial Agents and Chemotherapy 1961. American Society for Microbiology, p. 648 (1962)
Domino, E. F.: Human pharmacology of tranquilizing drugs. Clin. Pharmacol. Ther. 3, 599–664 (1962)
Domino, E. F. Psychosedative drugs I: Substituted phenothiazines, reserpine, and derivatives, pp. 337–355. In: J.R. Dipalma (Ed.), Drill’s Pharmacology in Medicine, 3rd edition. New York: McGraw-Hill Book Co. 1965
Dresse, A., Demeyer, R.: The inhibitory effect of eight neuroleptic drugs (butyrophenones and phenothiazines) on the rat brain noradrenaline increase produced by tranylcypromine. Biochem. Pharmacol. 14, 1129–1134 (1965)
Duhault, J., Boulanger, M.: Action of a new compound, 1-(3-trifluoromethylphenyl)-2-ethylaminopropane (TPEP), on lipid and carbohydrate metabolism. Rev. frang. Etud. elin. biol. 10, 215–216 (1965)
Domino, E. F., Fenard, S.: Study of the excretion, localization and metabolism of a new anorexigenic substance: fenfluramine. Arch. into Pharmacodyn. 158,251–264 (1965)
Domino, E. F., Verdavainne, C.: Alteration of the cerebral serotonin level of rats by 1-(trifluoromethylphenyl)-2-(ethylamino)propane (fenfluramine 768S). Arch. into Pharmacodyn. 170, 276–286 (1967)
Dunker, M.F.W., Grubb, T.C.: A study of the antibacterial activity of some fluorinated aromatic mercurials. J. Bact. 39, 243–254 (1940)
Eagleson, D.A.: Paper chromatographic differentiation of some important phenothiazines encountered in toxicology. Amer. J. elin. Path. 39, 648–651 (1963)
Ebert, A.G., Hess, S.M.: The distribution and metabolism of fluphenazine enenthate. J. Pharmacol. expo Ther. 148, 412–421 (1965)
Edgerton, L.J., Hoffman, M.B.: Fluorine substitution affects decarboxylation of 2,4-dichlorophenoxyacetic acid in apple. Science 134, 341–342 (1961)
Edmonds, E.J., Volkmann, C.M., Beerstecher, E., Jr.: Phenylserine studies. IV. Biochemical activity of o-and p-fluorophenylserine. Proc. Soc. expo Biol. Med. (N.Y.) 92, 80–82 (1956)
Einer-Jensen, N., Hansson, E.: Distribution in mice of 14C-γ-(4-methylpiperidino)-p-fluorobutyrophenone hydrochloride (FG5111), a butyrophenone derivative with tranquilizing properties. Acta pharmacol. (Kbh.) 23, 65–72 (1965)
Elmer, A.-W., Giedosz, B., Scheps, M.: Difluorotyrosine in experimental hyperthyroidism. C.R. Soc. Biol. (Paris) 129, 1225–1226 (1938)
Emmerson, J.L., Anderson, RC.: Metabolism oftrifluralin in the rat and dog. Toxicol. appl. Pharmacol. 9, 84–97 (1966)
Euler, H., Eichler, O.: The effect of organic fluorine compounds on the dental system of the rat. Arch. expo Pathol. Pharmakol. 199, 179–187 (1942)
Euler, H., Eichler, O., Hindemith, H.: The effects of several organic fluorides following repeated administration. Arch. expo Pathol. Pharmakol. 206, 75–82 (1949)
Fellman, J.H.: Fluoroarterenol: a fluorine isostere of norepinephrine. Nature (Lond.) 179, 265–266 (1957)
Finger, G.C., Reed, F.H., Tehon, L.R: Aromatic fluorine compounds. Illinois State Geological Survey Circular 199, Urbana, Illinois, pp. 15 (1955)
Finkelstein, J., Chiang, E., Lee, J.: Synthesis of cis- and trans-2-henoxycyclopropylamines and related compounds. J. med. Chem. 8,432–439 (1965)
Fischer, R., Hurni, H.: On benzisothiazolones: a series with a wide range of bacteriostatic and fungistatic activity. Arzneimittel-Forsch. 14, 1301–1306 (1964)
Flanagan, T.L., Newman, J.H., Maass, A.R., Van Loon, E.J.: Excretion patterns of phenothiazine-S35 compounds in rats. Effect of change in structure on metabolism. J. pharm. Sci. 51, 996–999 (1962)
Forrest, I. S., Forrest, F. M.: Urine color test for the detection of phenothiazine compounds. Clin. Chem. 6, 11–15 (1960)
Fosdick, L.S., Fancher, O., Urback, K.F.: Pressor amines containing nuclear chlorine and fluorine. J. Amer. chem. Soc. 68, 840–843 (1946)
Franko, B. V., Honkomp, L.J., Ward, J. W.: Cardiovascular and autonomic effects of fenfluramine hydrochloride. J. Pharm. Pharmacol. 17, 222–226 (1965)
Freeman, A. R., Spirtes, M. A.: Effects of chlorpromazine on biological membranes. II. Chlorpromazine-induced changes in human erythrocytes. Biochem. Pharmacol. 12, 47–53 (1963)
Frieden, E., Hsu, L. T., Dittmer, K.: Enzymatic degradation of amino acid antagonists. J. biol. Chem. 192, 425–433 (1951)
Gaetani, S., Spadoni, M.A.: Effect of 5-fluorouracil on hepatic induced increase of tryptophan-pyrrolase. Nature (Lond.) 191, 1296–1297 (1961)
Gal, E.M., Drewes, P.A., Taylor, N.F.: Metabolism of fluoracetic acid-2-C14 in the intact rat. Arch. Biochem. 93, 1–14 (1961)
Gale, G.R, Kendall, S.M., Bernheim, F.: Antimicrobial activity of thiobenzoate and its o-fluoro- and m-fluoro-derivatives. Proc. Soc. expo Biol. Med. (N.Y.) 115, 198–204 (1964)
Garzo, T., Hansson, E., Ullberg, S.: Uptake of C14-para-fluorophenylalanine in the tissue of mice. Experientia (Basel) 18, 43 (1962)
Gitterman, C. O.: Antitumor, cytotoxic, and antibacterial activities of tenuazonic acid and congeneric telramic acids. J. med. Chem. 8,483–486 (1965)
Glende, E. A., Cornatzer, W. E.: The effect of chlorpromazine, trifluoperazine and promethazine on brain sulfalipids. J. Pharmacol. expo Ther. 139,377–382 (1963)
Godin, C., Dolan, G.: The effects of phenylalanine analogues on the metabolism of phenylalanine in rats. Canad. J. Biochem. 45, 71–79 (1967)
Golab, T., Herberg, R.J., Parka, S.J., Tepe, J.B.: Metabolism of carbon-l4 trifluralin in carrots. J. Agr. Food Chem. 15, 638–641 (1967)
Goldemberg, L.: Treatment of Basedow’s disease and of hypertension with fluorine. Presse méd. 38, 1751–1755 (1930)
Goldman, P.: The enzymatic cleavage of the carbon-fluorine bond in fluoroacetate. J. biol. Chem. 240, 3434–3438 (1965)
Goldman, P., Milne, G.W.A.: Carbon-fluorine bond cleavage. II. Studies on the mechanism of the defluorination of fluoroacetate. J. biol. Chem. 241, 5557–5559 (1966)
Goldman, P., Milne, G.W.A., Keister, D. B.: Carbon-halogen bond cleavage. III. Studies on bacterial halidohydrolases. J. biol. Chem. 243, 428–434 (1968)
Goldman, P., Milne, G.W.A., Pignataro, M. T.: Fluorine containing metabolites formed from 2-fluorobenzoic acid by Pseudomonas species. Arch. Biochem. 118, 178–184 (1967)
Goodman, L., Gilman, A.: The Pharmacological Basis of Therapeutics, 3rd edition, p. 164. New York: The Macmillan Company 1965a
Goldman, P., Milne, G.W.A. Ibid. p. 172, 1965b
Goldman, P., Milne, G.W.A. Ibid. p. 844, 1965c
Goldman, P., Milne, G.W.A. Ibid. p. 839, 1965d
Gordon, M., Cook, L., Tedeschi, D.H., Tedeschi, R.E.: Some structure-activity relationships in the phenothiazines. Arzneimittel-Forsch. 13, 318–320 (1963)
Gorman, M., Hamill, R.L., Elander, R.P., Mube, J.: Preparation of substituted phenyl pyrroles through the metabolism of tryptophan analogues. Biochem. biophys. Res. Commun. 31, 294–298 (1968)
Gosfield, E.: The effect of bendroflumethiazide on serum uric acid and urinary clearance of uric acid. Curro ther. Res. 4, 158–164 (1962)
Gottlieb, A.A., Fujita, Y., Udenfriend, S., Witkop, B.: Incorporation of cis- and trans-4-fluoro-L-prolines into proteins and hydroxylation of the trans isomer during collagen biosynthesis. Biochem. J. 4, 2507–2513 (1965)
Graham, J.D.P.: 2-Halogenoalkylamines. In: G.P. Ellis and G.B. West (Eds.), Progress in Medicinal Chemistry, vol. 2, pp. 132–175. London: Butterworths 1962
Graham, J.D.P., Karrar, M.A.: Structure-action relations in N,N-dimethyl-2-halogenophenethylamines. J. med. Chem. 6, 103–107 (1963)
Graham, J.D.P., Lewis, G.P.: The antihistamine and antiadrenaline properties of a series of N-naphthylmethyl-2-haloethylamine derivatives. Brit. J. Pharmacol. 8, 54–61 (1953)
Graham, J.D.P., Lewis, G.P. The role of the cyclic ethylene-iminium ion in the pharmacological activity of the 2-haloethylamines. Brit. J. Pharmacol. 9, 68–5 (1954)
Granick, S.: Induction of the synthesis of o-aminolevulinic acid synthetase in liver parenchyma cells in culture by chemicals that induce acute porphyria. J. bioI. Chem. 238, PC 2247–2248 (1963)
Guroff, G., Fanning, G.R., Ceirigos, M.A.: Stimulation of aromatic amino acid transport by p-fluorophenylalanine in the Sarcoma 37 cell. J. cell. compo Physiol. 63, 323–332 (1964)
Guroff, G., King, W., Udenfriend, S.: The uptake of tyrosine by rat brain in vitro. J. biol. Chem. 236,1773–1777 (1961)
Guroff, G., Kondo, K., Daly, J.: The production of meta-chlorotyrosine from para-chlorophenylalanine by phenylalanine hydroxylase. Biochem. biophys. Res. Commun. 25, 622–628 (1966)
Guth, P.S., Spirtes, M.A.: The phenothiazine tranquilizers: biochemical and biophysical actions. In: C.C. Pfeiffer and J.R. Smythies (Eds.), Int. Rev. of Neurobiology, vol. 7, pp. 231–278. New York: Academic Press 1964
Haase, H.-J., Janssen, P.A. J.: The action of neuroleptic drugs. A psychiatric, neurologic and pharmacological investigation. Chicago: Year Book Medical Publishers, Inc. 1965
Hager, G.P., Starkey, E.B.: Fluorine substituted aromatic acids. J. Amer. pharm. Ass., Sci. Ed. 32, 44–49 (1943)
Von Hahn, H.P., Herrmann, H.: Effects of amino acid analogs on growth and catheptic activity of chick embryo explants. Develop. Biol. 5, 309–327 (1962)
Hall, D. M., Harris, M. M.: The steric effect of the trifluoromethyl group. Proc. chem. Soc. 396 (1959)
Hamm, P.C., Speziale, A.J.: Effect of variations in the acyl moiety on herbicidal activity of N-substituted alpha-chloroacetamides. Agr. Food Chem. 5, 30–32 (1957)
Harris, S. A., Fisher, L. V., Folkers, K.: The synthesis of tenuazonic and congeneric tetramic acids. J. med. Chem. 8,478–482 (1965)
Hartmann, H.A., Miller, E.C., Miller, J.A.: Periarteritis in rats given single injection of Δ’-fluoro-1O-methyl-1,2-benzanthracene. Proc. Soc. expo BioI. Med. (N.Y.) 101, 626–629 (1959)
Hasselmann, G., Roholt, K.: A note on the stability of the trifluoromethyl group of bendroflumethiazide in rats. J. Pharm. Pharmacol. 15,339–340 (1963)
Helin, A.F., Vander Werf, C.A.: Synthesis of medicinals derived from 5-fluoro-8-hydroxyquinoline. J. org. Chem. 17, 229–232 (1952)
Hellman, L., Bradlow, H.L., Zumoff, B., Fukusmma, D.K., Gallagher, T.F.: Thyroidandrogen interrelationships and the hypocholsterolemic effect of androsterone. J. clin. Endocrinol. Metab. 19, 936–948 (1959)
Hendry, J.A., Matthews, J.J., Walpole, A.L., Williams, M.H.C.: Tumors induced in rats with 4’-fluoro-4-aminodiphenyl. Nature (Lond.) 175, 1131 (1955)
Hester, J.B., Greig, M.E., Anthony, W.C., Heinzelman, R.V., Szmuszkovicz, J.: Enzyme inhibitory activity of3-(2-aminobutyl) indole derivatives. J. med.Chem. 7, 274–279 (1964)
Heymann, B., Gruig, T. C.: Further studies of the antibacterial activity of some fluorinated aromatic mercurials. J. Bact. 40, 363–371 (1940)
High, J.P., Hassert, G.L., Jr., Rubin, B., Piala, J.J., Burke, J.C., Craver, B.N.: Pharmacology of fluphenazin (prolixin). Toxicol. appl. Pharmacol. 2, 540–552 (1960)
Hirsch, P., Alexander, M.: Microbial decomposition of halogenated propionic and acetic acids. Canad. J. Microbiol. 6, 241–249 (1960)
von Hodenberg, F.: The treatment of hyperthyroidism with fluorotyrosine. Dent. med. W schr. 67, 706–709 (1941)
Hodge, H.C., Smith, F.A., Chen, P.S.: Biological effects of organic fluorides. In: J.H. Simons (Ed.), Fluorine Chemistry, cf. pp. 47–48, tables 131–148. New York: Academic Press 1963
Hökfelt, B., Jönsson, Å.: Hypoglycemic activity in relation to chemical structure of potential oral antidiabetic substances. I. 1.sulfonyl-3-alkylureas. J. med. pharm. Chem. 5, 231–239 (1962a)
Hökfelt, B., Jönsson, Å.: Hypoglycemic activity in relation to chemical structure of potential oral antidiabetic substances. II. Analogs of l-sulfonyl-3.alkylureas. J. med. pharm. Chem. 5, 240–246 (1962b)
Hökfelt, B., Jönsson, Å.: Hypoglycemic activity in relation to chemical structure of potential oral antidiabetic substances. III. 2-Benzene-sulfonamido-5-alkyl-l,3,4-thiadiazoles and -oxadiazoles. J. med. pharm. Chem. 5, 247–257 (1962c)
Hoffman, P.P., Madison, R.K., Hardy, W.B.: The synthesis of N-hydroxycarbanilides and their evaluation as germicides. J. med. Chem. 7, 665–668 (1964)
Holderness, M.C., Chase, P.E., Dripps, R.D.: A narcotic analgesic and a butyrophenone with nitrous oxide for general anesthesia. Anesthesiology 24, 336–340 (1963)
Holland, G.F., Buck, C.J., Weissman, A.: Anorexigenic agents: aromatic substituted 1-phenyl-2-propylamines. J. med. Chem. 6, 519–524 (1963)
Holland, G.F., Jaeger, D.A., Wagner, R.L., Lauback, G.D., McLamore, W.M., P’an, S.Y.: Hypoglycemic activity in a series of l-aryl-3-arylsulphonylureas. J. med. pharm. Chem. 3, 99–110 (1961)
Holland, W.C., Klein, R.L., Briggs, A.H.: Introduction to Molecular Pharmacology. New York, N.Y.: The Macmillan Co. 1964
Hoover, J.R.E., Chow, A.W., Stedman, R.J., Hall, N.M., Greenberg, H.S., Dolan, M. M., Ferlanto, R. J.: Semisynthetic penicillins. I. 2-Biphenylylpenicillins. J. med. Chem. 7, 245–251 (1964)
Horikawa, E.K., Steelman, R., Flanagan, T.L., Van Loon, E.J.: Determination of fluorideion in femers of rats receiving organic fluoride. J. med. pharm. Chem. 2, 541–551 (1960)
Horita, A.: β-Phenylisopropylhydrazine, a potent and long acting monoamine oxidase inhibitor. J. Pharmacol. expo Ther. 122, 176–181 (1958)
Horiuchi, N.: C-F bond rupture in monofluoroacetate by soil microbes. II. Some properties of the bacteria and the enzyme. Seikagaku 34, 92–98 (1962a)
Horiuchi, N. Splitting of the carbon-fluorine bond of sodium monofluoroacetate in the animal body. Kogyo Kagaku Zasshi 65, 1177–1179 (1962b)
Hughes, D. E.: 6-Hydroxynicotinic acid as an intermediate in the oxidation of nicotinic acid by Pseudomonas fluorescens. Biochem. J. 60, 303–310 (1955)
Hughes, G.M.K., Moore, P.F., Stebbins, R.B.: Some hypocholesteremic 2,3-diphenylacrylonitriles. J. med. Chem. 7, 511–518 (1964)
Hughes, G.M.K, Saunders, B. C.: Studies in peroxidase action. Part IX. Reactions involving the rupture of the C-F, C-Br, and C-I links in aromatic amines. J. chem. Soc. 4630–4634 (1954)
Hyde, K.A., Acton, E., Skinner, W.A., Goodman, L., Greenberg, J., Baker, B.R.: Potential anticancer agents. LXII. The relationship of chemical structure to antileukemic activity with analogs of I-methyl-3-nitro-l-nitrosoguanidine (NSC-9369). II. J. med. pharm_ Chem. 5, 1–14 (1962)
Ichihara, A., Adachi, K., Hosokawa, K., Takeda, Y.: The enzymatic hydroxylation of aromatic carboxylic acids; substrate specificities of anthranilate and benzoate oxidases. J. biol. Chem. 237, 2296–2302 (1962)
Jackman, G.B., Petrow, V., Stephenson, O., Wild, A.M.: Studies in the field of diuretic agents. Part VI. Some sulphamoylbenzoic acids. J. Pharm. Pharmacol. 14, 679–686 (1962)
Janssen, P.A.J.: Vergleichende pharmakologische Daten über sechs neue basische 4’-Fluorobutyrophenon-Derivate. Haloperidol, Haloanison, Triperidol, Methylperidid, Haloperidid und Dipiperon. Arzneimittel-Forsch. 11, 819–824, 932–938 (1961)
Janssen, P.A.J. The evolution of the butyrophenones, haloperidol and trifluperidol, from meperidine-like 4-phenylpiperidines. In: C.C. Pfeiffer and J. R. Smythies (Eds.), Int. Rev. Neurobiology, vol. 8, pp. 221–263. New York: Academic Press 1965
Janssen, P.A.J, Jageneau, A.H.M., Demoen, P.J.A., van De Westeringh, C., De Canniere, J.H.M., Raeymaekers, A.H.M., Wouters, M.S.J., Sanczuk, S., Hermans, B.K.F.: Compounds related to pethidine. III. Basic ketones derived from norpethidine. J. med. pharm. Chem. 2, 271–280 (1960)
Janssen, P.A.J, Niemegeers, J.E., Schellekens, K.H.L., Verbruggen, F.J., van Nueten, J. M.: The pharmacology of dehydrobenzperidol, a new potent and short acting neuroleptic agent chemically related to haloperidol. Arzneimittel-Forsch. 13, 205–211 (1963)
Janssen, P.A.J, Van De Westeringh, C., Jageneau, A.H.M., Demoen, P.J.A., Haemans, B.K.F., Van Daele, G.H.P., Schellekens, K.H.L., Van Der Eycken, C.A.M., Niemegeers, C.J.E.: Chemistry and pharmacology of CNS depressants related to 4-(4-hydroxy-4-phenylpeperidino) butyrophenone. Part. I. Synthesis and screening data in mice. J. med. pharm. Chem. 1, 281–297 (1959)
Johnston, T.P., McCaleb, G.S., Montgomery, J.A.: The synthesis of antineoplastic agents. XXXII. N·Nitrosoureas. I. J. med. Chem. 6, 669–681 (1963)
Jones, O.T.G., Watson, W.A.: Activity of 2-trifluoromethylbenzimidazoles as uncouplers of oxidative phosphorylation. Nature (Lond.) 208, 1169–1170 (1965)
Jones, R.G., Soper, Q.F., Behrens, O.K., Corse, J.W.: Biosynthesis of penicillins. VI. N-2-Hydroxyethylamides of some polycyclic and heterocyclic acetic acids as precursors. J. Amer. chem. Soc. 70, 2843–2848 (1948)
Jordin, M.W., Easterly, W.D., Jr., Winningham, T.E., Hubbard, W.C.: Synthesis and pharmacological properties of some fluorine-containing amide derivatives. J. pharm. Sci. 54, 1190–1193 (1965)
Jorgensen, E. C.: Stereochemistry of thyroxin and analogues. Mayo Clinic Proc. 39, 560–568 (1964)
Jucker, E., Lindemann, A., Schenker, E., Flüciuger, E., Toeschler, M.: Konstitution and salidiuretischer Effekt von 3-Sulfamyl-4-chlorbenzeneolsaure-Derivaten und verwandten Verbindungen. Arzneimittel-Forsch. 13, 269–280 (1963)
Kato, R., Chiesara, E., Vassanelli, P.: Factors influencing induction of hepatic microsomal drug-metabolizing enzymes. Biochem. Pharmacol. 11,211–220 (1962)
Kaufman, S.: The enzymic conversion of 4-fluorophenylalanine to tyrosine. Biochim. biophys. Acta (Amst.) 51, 619–621 (1961)
Kelly, M.: Isolation of bacteria able to metabolize fluoroacetate or fluoroacetamide. Nature (Lond.) 208, 809–810 (1965)
Kempf, C.A., Greenwood, D.A., Nelson, V.E.: Studies relating to the toxicity of fluorine compounds. J. Lab. elin. Med. 22, 1133–1137 (1936/37)
Khazan, N., Primo, C., Danon, A., Assael, M., Suliman, F.G., Winnik, H.A.: The mammotropic effect of tranquilizing drugs. Arch. into Pharmacodyn. 136, 291–305 (1962)
Klimstra, P.D., Counsell, R.E.: Hypocholesterolemic agents. II. 2β-Halo·5α-androstane derivatives. J. med. pharm. Chem. 5, 1216–1224 (1962)
Knight, R. H., Young, L.: Biochemical studies of toxic agents. II. The occurrence of premercupturic acid. Biochem. J. 70, 111–119 (1958)
Kobinger, W., Katic, U.: Experimental investigations into two hydrothiadiazine derivatives with potent diuretic action. Wien. klin. Wschr. 71, 545–549 (1959)
Kobinger, W., Katic, U Pharmakologische Eigenschaften von Benzylhydroflumethiazid, einem neuen, oral wirksamen Diureticum. Arch. expo Pathol. Pharmakol. 238, 435–453 (1960)
Kobinger, W., Lund, F.J.: Investigations into a new oral diuretic, Rontyl (6-trifluoromethyl-7 -sulfamyl-3,4-dihydro-l,2,4-benzothiadiazine-l,1-dioxide). Acta pharmacol. (Kbh.) 15, 265–274 (1959)
Kobinger, W., Katic, U, Roholt, K.: Centyl (bendroflumethiazide). Experimental studies with a new oral diuretic. J. Irish med. Ass. 47, 81–85 (1960)
Koe, B. K., Weissman, A.: Convulsions and elevation of tissue citric acid levels induced by 5-fluorotryptophan. Biochem. Pharmacol. 15, 2134–2136 (1966)
Koe, B. K., Weissman, A, Dependence of m-fluorophenylalanine toxicity on phenylalanine hydroxylase activity. J. Pharmacol. expo Ther. 157, 565–573 (1967)
Korczak-Fabierkiewicz, C., Kofoed, J., Lucas, G. H. W.: The sulfoxides as an additional rapid test for phenothiazine tranquilizers. J. forens. Sci. 10, 308–312 (1965)
Kraft, K.: Antagonism of fluorine and thyroxin. Z. physiol. Chem. 245, 58–64 (1936)
Krantz, J.C., Jr., Rudo, F.G.: The fluorinated anesthetics. In: F.A. Smith (Ed.), Handbuch der experimentellen Pharmakologie, vol. XX/I, pp. 501–559. Berlin.Heidelberg-New York: Springer 1966
Kreppel, E.: Tierexperimenteller Beitrag zum Wirkungsspektrum einiger ButyrophenonDerivate. Arzneimittel-Forsch. 16,257–258 (1966)
Kruh, J., Rosa, J.: Incorporation in vitro de [14C] fluorophenylalanine dans l’hemoglobine des reticulocytes de lapin. Biochim. biophys. Acta (Amst.) 34, 561–563 (1959)
Kun, E., Fanshier, D. W., Grassetti, D. W.: Interaction between β-fluoro-oxaloacetate and glutamate-aspartate transaminase of heart mitochondria. J. bioI. Chem. 235, 416–419 (1960)
Lands, A.M.: The effect on blood pressure and toxicity of 1-(3-fluorophenyl)-2-aminoethanol and related compounds. J. Pharmacol. expo Ther. 106, 440–443 (1952)
Lang, K.: The effect of organic fluorine compounds on the animal organism. I. The effect of fluorobenzene, p-fluorotoluene and p-fluoroacetanilide. The state of fluorine in blood. Arch. expo Pathol. Pharmakol. 152, 361–376 (1930)
Ledouarec, J.C., Schmitt, H., Laubie, M.: Pharmacologic study of fenfluramine and its optical isomers. Arch. into Pharmacodyn. 161, 206–232 (1966)
Lehmann, F.: Chemical constitution and activity. Aromatic fluorine compounds. Arch. expo Pathol. Pharmakol. 130,250–255 (1928)
Leonard, E.O., Skinner, C. G., Shive, W.: Synthesis of 2-fluoro-6-benzylaminopurine and other purine derivatives. Arch. Biochem. 92, 33–37 (1961)
Levy, B., Ahlquist, R.P.: An analysis of adrenergic blocking activity. J. Pharmacol. expo Ther. 133, 202–210 (1961)
Lieberman, I., Abrams, R., Hunt, N., Ove, P.: Levels of enzyme activity and deoxyribonucleic acid synthesis in mammalian cells cultured from the animal. J. biol. Chem. 238, 3955–3962 (1963)
Lilly, V.G.: The effects of the monohalogenacetic acids on growth and carotenogenesis of Phycomyces blakesleeanus. Proc. West Virginia Acad. Sci. 36, 45–52 (1964)
Litzka, G.: Biological action of a fluorinated amino acid (fluorotyrosine). Arch. expo Pathol. Pharmakol. 183, 427–435 (1936a)
Litzka, G The antithyrotoxic action of fluorotyrosine. Arch. expo Pathol.Pharmakol. 183, 436–458 (1936b)
Loev, B., Snader, K.M., Walz, D. T.: The synthesis of some new sulfonylureas. J. med. Chem. 6, 506–508 (1963)
Lovelace, J., Miller, G. W., Welkie, G. W.: The accumulation of fluoroacetate and fluorocitrate in forage crops collected near a phosphate plant. Atmos. Environ. 2, 187–190 (1968)
Lombardino, J.G.: 4,6-Diamino-1-alkyl-1,2-dihydro-5-triazines. J. med. Chem. 6, 213–214 (1963)
Lombardino, J.G, Gerber, C.F.: Preparation and hypoglycemic activity of some 3,5-disubstituted hydantoins. J. med. Chem. 7, 97–101 (1964)
Loncrini, D.F., Walborsky, H.M.: The synthesis of 2-amino-3-trifluoromethylbutyric acid. J. med. Chem. 7, 369 (1964)
Long, G., Dripps, R. D., Price, H. L.: Measurement of anti-arrhymic potency of drugs in man: effects of dehydrobenzperidol. Anesthesiology 28, 318–323 (1967)
Loynes, J.M., Ridley, H.F., Spickett, R.G. W.: New sulfonamides. J. med. Chem. 8, 691–694 (1965)
Lucas, G.A.W., Fabierkiewicz, C.: Useful tests to identify phenothiazine tranquilizers. J. forens. Sci. 8,462–476 (1963)
Mamalis, P., Jeffries, L., Price, S.A., Rix, M.J., Outred, D.J.: Aminooxy derivatives. IV. Antimicrobial activity of some O-ethers of 4,6-diamino-1,2-dihydro-1-hydroxy-2-substituted 1,3,5-triazines. J. med. Chem. 8, 684–691 (1965)
MAo, T.S.S., Noval, J.J.: Some relationships concerning the chemical structure, hemolytic activity, and therapeutic potency of phenothiazines. Biochem. Pharmacol. 15, 501–504 (1966)
Marais, J.S.C.: Monofluoroacetic acid, the toxic principle of “Gifblaar”, Dichapetalum cymasum (Hook), Engl. Onderstepoort J. vet. Sci. Anim. Ind. 20, 67–73 (1944)
Maren, T.H., Wiley, C.E.: Renal activity and pharmacology of N-acyl and related sulfonamides. J. Pharmacol. expo Ther. 143, 230–242 (1964)
Margasinski, Z., Danielak, R., Pomazanska, T., Rafalowska, H.: Separation of phenothiazine derivatives by thin-layer chromatography. Acta Pol. pharm. 21, 253–256 (1964)
Marsh, D.F.: The comparative pharmacology of p-fluorophenethylamine and p-fluorophenethyl-methylamine. J. Pharmacol. expo Ther. 94, 192–196 (1948)
Martin, G.J., Moss, J.N.: In vitro effects of metabolic displacers on Pseudomohas aeruginosa. Amer. J. Pharm. 121, 169–172 (1949)
Maumené, E.: Tests to determine the action of fluorides on the animal organism. Compt. rend. 39, 538–540 (1854)
Maung, M., Tin, Lagowski, J.J., Cosgrove, F.P., Delgado, J.N.: Effect of the trifluoromethyl group on biological activity of certain arylmercurials. J. pharm. Sci. 53, 330–332 (1964)
May, H., Litzka, G.: Über die Hemmung des Tumorwachstums durch Fluortyrosin. Z. Krebsforsch. 48, 376–383 (1939)
May, R.: Experience in the treatment of hyperthyroidism and Basedow’s disease with an organic fluorocompound (fluoroxyphenylacetic acid, “Capacin”). Dtsch. med. Wschr. 74, 374–375 (1949)
May, R. Therapy with organic compounds of fluorine. Med. Mschr. 4, 489–491 (1950)
Mcewan, T.: Isolation and identification of the toxic principle of Gastrolobium grandiflurum. Nature (Lond.) 201, 827 (1964)
Mcilwain, H.: Actions of haloperidol, meperidine, and related compounds on the excitability and ion content of isolated cerebral tissue. Biochem. Pharmacol. 13, 523–529 (1964)
Mclane, S.R., Dean, E.W., Brown, J.W., Connell, C.R., Howard, W.H., Minarik, C.E.: Halogenated phenyl alkyl ethers as plant growth regulators. Weeds 2, 289–291 (1953)
McManus, J.M., Mcfarland, J.W., Gerber, C.F., McLamore, W.M., Lauback, G.D.: Sulfamylurea hypoglycemic agents. I. Synthesis and screening. J. med. Chem. 8, 766–776 (1965)
Mellinger, T.J., Keeler, C.E.: Chromatography and electrophoresis of phenothiazine drugs. J. pharm. Sci. 51, 1169–1173 (1962)
Mellinger, T.J., Keeler, C.E Spectrofluorometric identification of phenothiazine drugs. Anal. Chem. 35, 554–558 (1963)
Mercier, J., Etzensperger, P.: Contribution à l’étude pharmacologique de la fluphenazine (4,3,2-(trifluoromethyl) 10-phenothiazinyl-propylpiperazine ethanol). I. Etude psychopharmacologique. Arch. into Pharmacodyn. 145,450–478 (1963)
Metcalf, R. L.: Fluorine-containing insecticides. In: F. A. Smith (Ed.), Handbuch der experimentellen Pharmakologie, vol. XX/I, pp. 355–386. Berlin-Heidelberg-New York: Springer 1966
Miller, E.C., Fletcher, T.L., Margreth, A., Miller, J.A.: The carcinogenicities of derivatives of fluorene and biphenyl: fluoro derivatives as probes for active sites in 2-acetylamino-fluorene. Cancer Res. 22, 1002–1014 (1962)
Miller, E.C, Lotlikar, P.D., Pitot, H.C., Fletcher, T.L., Miller, J.A.: N-hydroxy metabolites of 2-acetylaminophenanthrene and 7 -fluoro-2.acetylaminofluorene as proximate carcinogens in the rat. Cancer Res. 26, 2239–2247 (1966)
Miller, E.C, Miller, J.A.: Biochemical investigations on hepatic carcinogenesis. J. nat. Cancer Inst. 15, 1571–1590 (1955)
Miller, E.C, Miller, J.A.: The carcinogenicity offluoro derivatives of l0-methyl-l,2-benzanthracene. I. 3- and 4’· monofluoro derivatives. Cancer Res. 20, 133–137 (1960)
Miller, E.C, Miller, J.A. Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromolecules. Pharmacol. Rev. 18,805–838 (1966)
Miller, E.C, Miller, J.A, Brown, R.R., Macdonald, J.C.: On the protective action of certain polycyclic aromatic hydrocarbons against carcinogenesis by aminoazo dyes and 2-acetylaminofluorene. Cancer Res. 18, 469–477 (1958)
Miller, E.C, Miller, J.A, Sapp, R.W., Weber, G.M.: Studies on the protein-bound aminoazo dyes found in vivo from 4-dimethylaminoazobenzene and its C-monomethyl derivatives. Cancer Res. 9, 336–343 (1949)
Miller, E.C, Sandin, R.B., Miller, J.A., Rusch, H.P.: The carcinogenicity of compounds related to 2-acetylaminofiuorene. III. Aminobiphenyl and benzidine derivatives. Cancer Res. 16, 525–534 (1956)
Miller, J.A., Miller, E.C.: The carcinogenic aminoazo dyes. In: J.P. Greenstein and A. Haddow (Eds.), Advances in Cancer Research, vol. I, pp. 339–396. New York: Academic Press Inc. 1953
Miller, E.C, Miller, J.A The carcinogenicities of fiuoro derivatives of lO-methyl-l,2-benzanthracene. II. Substitution ofthe K region and the 3’-, 6, and 7-positions. Cancer Res. 23, 229–239 (1963)
Miller, E.C, Miller, J.A, A survey of molecular aspects of chemical carcinogenesis. Lab. Invest. 15, 217–241 (1966)
Miller, E.C, Miller, J.A, Finger, G.C.: On the enhancement of the carcinogenicity of 4-dim ethylaminoazobenzene by fiuoro-substitution. Cancer Res. 13, 93–97 (1953)
Miller, E.C, Miller, J.A, Miller, E.C, Further studies on the carcinogenicity of dyes related to 4-dimethylaminoazobenzene. The requirement for an unsubstituted 2-position. Cancer Res. 17,387–398 (1957)
Miller, E.C., Sapp, R. W., Miller, E. C.: The carcinogenic activities of certain halogen derivatives of 4-dimethylaminoazobenzene in the rat. Cancer Res. 9, 652–660 (1949)
Miller, E.C, Sandin, R. B., Miller, E. C., Rusch, H. P.: The carcinogenicity of compounds related to 2-acetylaminofiuorene. II. Variations in the bridges and the 2-substituent. Cancer Res. 15, 188–199 (1955)
Miller, R.F., Phillips, P.H.: Effect of feeding fiuoroacetate to the rat. Proc. Soc. expo Biol. Med. (N.Y.) 89, 411–413 (1955)
Milne, M.D.: Diuretics and electrolyte balance. In: J.M. Robson and R.S. Stacey (Eds.), Recent Advances in Pharmacology, 3rd edition, pp. 248–249. London: J. and A. Churchill Ltd. 1962
Minarik, C. E., Ready, D., Norman, A. G., Thompton, H. E., Owings, J. F. JR.: New growthregulating compounds. II. Substituted benzoic acids. Botan. Gaz. 113, 135–147 (1951)
Minor, J. T., Hawkins, G.F., Vander Werf, C.A., Roe, A.: Synthesis of 2- and 6-fiuoronicotinamides. J. Amer. chem. Soc. 71, 1125–1126 (1949)
Mitchell, H. K., Niemann, C.: The competitive inhibition of the metabolism of a’amino acids by their halogenated analogs. J. Amer. chem. Soc. 69, 1232 (1947)
Montero, A.C., Rochelle, J.B., Ford, R.V.: Use of fiumethiazide as an adjunct to the therapy of hypertension. New Engl. J. Med. 260, 872–873 (1959)
Morpurgo, C.: Influence of phenothiazine derivatives on the accumulation of brain amines induced by monoamine oxidase inhibitors. Biochem. Pharmacol. 11, 967–972 (1962)
Morpurgo, C., Theobald, W.: Influence of antiparkinson drugs and amphetamine on some pharmacological effects of phenothiazine derivatives used as neuroleptics. Psychopharmacologia (Berl.) 6, 178–191 (1964)
Morris, H.P.: Hepatocarcinogenesis by 2-acetylaminofluorene and related compounds including comments on dietary and other influences. J. nat. Cancer lust. 15, 1535–1547 (1955)
Morris, H.P, Velat, C.A., Wagner, B.P.: Carcinogenicity of some ingested acetylated mono- and diaminobiphenyl compounds in the rat. J. nat. Cancer Inst. 18, 101–115 (1957)
Morris, H.P, Velat, C.A., Wagner, B.P, Dahlgard, M., Ray, F.E.: Studies of carcinogenicity in the rat of derivatives of aromatic amines related N-2-fluorenylacetamide. J. nat. Cancer Inst. 24, 149–180 (1960)
Morris, H.P, Wagner, B.P., Ray, F.E., Snell, K.C., Stewart, H.L.: Comparative study of cancer and other lesions of rats fed N,N’ -2, 7 -fluorenylene-bisacetamide or N -2-fluorenylacetamide. Nat. Cancer Inst. Monogr. 5, 1–53 (1961)
Morris, H.P, Wagner, B.P., Ray, F.E., Stewart, H.L., Snell, K.C.: CarcinogeniceffectsofN,N’-2,7-fluorenylen&bis-2,2,2- trifluoroacetamide (2,7-F.A.A-F6) administered orally to Buffalo strain rats. J. nat. Cancer Inst. 30, 143–161 (1963)
Morris, R. W.: Effects of phenothiazines on pentobarbital-induced sleep in mice. Arch. into Pharmacodyn. 161, 380–391 (1966)
Murray, L.R., McConnell, J.D., Whittem, J.H.: Suspected presence of fluoroacetate in Acacia georginae F.M. Bailey. Aust. J. Sci. 24, 41–42 (1961)
Neff, N., Rossi, G. V.: A pharmacologic evaluation of trifluorinated phenothiazines. Arch. into Pharmacodyn. 136,476–483 (1962)
Nemeth, A.M.: The effect of 5-fluorouracil on the developmental and adaptive formation of tryptophan pyrrolase. J. biol. Chem. 237, 3703–3706 (1962)
Nemeth, L., Olar, G., Sellei, C., Gati, E., Kellner, B.: Chemotherapeutische Versuche mit organischen Fluorverbindungen an Tierkrebsen. Arch. Geschwulstforsch. 11, 101–111 (1957)
Nes, W. R., Burger, A.:.Amine and enol derivatives of 1,1,1-trifluoropropane. J. Amer. chem. Soc. 72, 5409–5413 (1950)
Niedner, K.: mer die Wirkung des 3-Fluortyrosins auf den Ascitestumor der Maus. Z. Krebsforsch. 51, 159–163 (1941)
Niemann, C., Rapport, M.M.: The toxicity of 3-fluoro-d(+)- and -1(–)-tyrosine. J..Amer. chem. Soc. 68, 1671–1672 (1946)
Nodine, J.H., Bodi, T., Levy, H.A., Siegler, P.E., Slap, J.W., Mapp, Y., Khorsandian, R., Slemmer, K., Beyer, M., Sprague, F.: Modified technique used in human bioassay of four butyrophenone derivatives in psychoneurotic patients. Clin. Pharmacol. Ther. 3, 432–440 (1962)
Novello, F.C., Bell, J.C., Abrams, E.L.A., Ziegler, C., Sprague, J.M.: Diuretics: aminobenzenedisulfonamides. J. org. Chem. 25, 965–970 (1960a)
Novello, F.C., Bell, J.C., Abrams, E.L.A., Ziegler, C., Sprague, J.M.: Diuretics: 1,2,4-benzothiadiazine-l, I-dioxides. J. org. Chem. 25, 970–981 (1960b)
Novello, F.C., Sprague, J. M.: Benzothiadiazine dioxides as novel diuretics. J. Amer. chem. Soc. 79, 2028–2029 (1957)
Oelrichs, P.B., Mcewan, T.: Isolation of the toxic principle in Acacia georginae. Nature (Lond.) 190, 808–809 (1961)
De Oliveira, M.M.: Chromatographic isolation of monofluoroacetic acid frpm Palicourea marcgravii St. Hil. Experientia (Basel) 19, 586–587 (1963)
Ott, E.: Organische Fluorverbindungen zur Kariesprophylaxe. Schweiz. Mschr. Zahnheilk. 65, 780–783 (1955)
Ott, E., Piller, G., Schmidt, H.J.: mer eine neue Synthese der 5-Fluor-n-Valeriansaure und ihrer Ester und Glyceride und iiber deren Anwendung zur Zahnhartung und Prophylaxe der Zahnkaries. Helv. chim. Acta 39, 682–685 (1956)
Palazzo, G., Tavella, M., Stranl, G.: A new class of hypocholesteremic agents: arylalkyl hydrogen succinates and glutarates. J. med. pharm. Chem. 4,447–456 (1961)
Pan, Hsi-Lung, Fletcher, T.L.: Derivatives of fluorene. XVII. New halogenofluorenes. I. Potential antitumor agents. J. med. Chem. 7, 31–38 (1964)
Pan, Hsi-Lung, Fletcher, T.L. Derivatives of fluorene. XXI. New halogenofluorenes. II. Further potential antitumor agents. J. med. Chem. 8, 491–497 (1965)
Pattison, F.L.M.: From war to peace: toxic aliphatic fluorine compounds. Chem. in Canada 9, 27 (1957)
Pattison, F.L.M: Toxic Aliphatic Fluorine Compounds. Amsterdam: Elsevier Publ. Co. 1959
Pattison, F.L.M, Peters, R.A.: Monofluoro aliphatic compounds. In: F.A. Smith (Ed.), Handbuch der experimentellen Pharmakologie, vol. XX/I, pp. 387–458. Berlin-Heidelberg-New York: Springer 1966
Pattison, F. L. M. Saunders, B.C.: Toxic fluorine compounds containing the C-F link. Part VII. Evidence for the oxidation of w-fluorocarboxylic acids in vivo. J. chem. Soc., 2745–2749 (1949)
Perelman, M., Mizsak, S.: 2,2,2-triarylpropionitriles and related compounds as hypocholesterolemic agents. J. med. Chem. 6, 533–538 (1963)
Perrine, J. W., Bortle, L., Heyden, E., Partrideg, R., Ross, E.K., Ringler, I.: Adrenal corticoid activities of 9α-fluoro-llp, 11β, 17 α,21-tetrahydroxy -1,4-prenadiene-3,20-dione. Endocrinology 64, 437–447 (1959)
Perron, Y.G., Pindell, M.H., Crost, L.B., Cheney, L.C.: Synthesis and hypoglycemic activity of trifluoromethylated sulphonylureas. J. med. pharm. Chem. 4, 41–49 (1961)
Peters, R., Shorthouse, M.: Fluoride metabolism in plants. Nature (Lond.) 202, 21–22 (1964)
Peters, R.A.: Some adventures in biochemical pharmacology. Rec. chem. Progr. 28, 197–209 (1967a)
Peters, R.A. Experiments upon the biochemistry of the synthesis of fluoroacetate in the Australian Acacia georginae and their significance. Rev. Roum. Biochim. 4, 79–91 (1967b)
Peters, R.A., Hall, R.J., Ward, P.F. V., Sheppard, N.: The chemical nature of the toxic compounds containing fluorine in the seeds of Dichapetalum toxicarium. Biochem. J. 77, 17–23 (1960a)
Peters, R.A, Murray, L.R., Shorthouse, M.: Fluoride metabolism in Acacia georginae Gidyea. Biochem. J. 95, 724–730 (1965a)
Peters, R.A, Shorthouse, M., Observations on the metabolism of fluoride in Acacia georginae and some other plants. Nature (Lond.) 216, 80–81 (1967)
Peters, R.A, Shorthouse, M., Ward, P.F.V.: The synthesis of the carbon-fluorine bond by Acacia georginae in vitro. Life Sci. 4, 749–752 (1965b)
Piala, J.J., High, J.P., Hassert, G.L., Jr., Burke, J.C., Craver, B.N.: Pharmacological and acute toxicological comparisons oftriflupromazine and chlorpromazine. J. Pharmacol. expo Ther. 127, 55–65 (1959)
Piala, J.J., Poutsiaka, J.W., Smith, C.I., Burke, J.C., Craver, B.N.: Pharmacology of benzydroflumethiazide (naturetin). J. Pharmacol. expo Ther. 134, 273–280 (1961)
Pinson, R., Jr., Schreiber, E.C., Wiseman, E.H., Cmainl, J., Baumgartner, D.: The fate and excretion of polythiazide in the dog. J. med. pharm. Chem. 5, 491–503 (1962)
Pitotti, G.: On the effects of sodium fluoride on various organs and on the tissual element of the animal organism. Bol. sci. med. Bologna 4 (5–7), 5–22 (1893)
Podrebarac, E. G., Cheng, C. C.: Studies on methylglyoxal bis (guanylhydrazone) analogs. III. Trifluoromethylglyoxal bis (guanylhydrazone) and 1,2-bis (guanadinoamino) propane. J. med. Chem. 7, 806–808 (1964)
Popp, F. D.: Synthesis of potential anticancer agents. VIII. Benzaldehyde mustard derivatives and related compounds. J. med. pharm. Chem. 5, 627–629 (1962)
Popp, F. D. Synthesis of potential antineoplastic agents. X. Preparation and reactions of aldehydes related to benzaldehyde mustard. J. med. pharm. Chem. 7, 210–212 (1964)
Poutsiaka, J.W., Fiala, J.J., Smith, C.I., Burke, J.C., Thomas, B.G.H.: Pharmacologic studies of flumethiazide (ademol). J. Pharmacol. expo Ther. 128, 405–413 (1960)
Prescott, B., LI Chenpein: Long-chain thiosemicarbazones as potential anticancer and antiviral agents. J. med. Chem. 7, 383–385 (1964)
Preuss, P.W., Lemmens, A.G., Weinstein, L.H.: Studies on Huoro-organic compounds in plants. I. Metabolism of 2_14C-fluoroacetate. Contr. Boyce Thompson Inst. 24, 25–31 (1968)
Preziosi, P., Miele, E., Marmo, E.: Influence de la benzhydroflumethiazide.sur les effets hypotenseurs de la reserpine. Arch. into Pharmacodyn. 132,454–464 (1961)
Preziosi, P., Miele, E., Marmo, E.: Experimental research on the antiangious effects of hydrochlorothiazide and other benzothiazine diuretics. Arch. into Pharmacodyn. 140, 308–318 (1962)
Price, J. M., Harman, J. W., Miller, E. C., Miller, J. A.: Progressive microscopic alterations in the livers of rats fed the hepatic carcinogens 3’methyl-4-dimethylamino-azobenzene and 4’fluoro-4-dimethylamino-azobenzene. Cancer Res. 12, 192–200 (1952)
Price, J. M., Miller, E.C., Miller, J.A., Weber, G.M.: Studies on the intracellular composition of livers from rats fed various aminoazo dyes. II. 3’-Methyl-, 2’-methyl-, and 2-methyl-4- dimethylaminoazobenzene, 3-methyl-4-monomethylaminoazobenzene, and 4’-fluoro-4- dimethylaminoazobenzene. Cancer Res. 10, 18–27 (1950)
Probst, G.W., Golab, T., Herberg, R.J., Holzer, F.J., Parka, S.J., Vander Schans, C., Tepe, J.B.: Fate oftrifluralin in soils and plants. J. Agr. Food Chem. 15,592–599 (1967)
Psychoyos, A.: A study of the hormonal requirements for ovum implantation in the rat, by means of delayed nidation-inducing substances (chlorpromazine, trifluoperazine). J. Endocr. 27, 337–343 (1963)
Pullman, A., Pullman, B.: Electron transfer and carcinogenesis. Nature (Lond.) 196,228–229 (1962)
Rarinovita, M., Olson, M.E., Greenberg, D.M.: Independent antagonism of amino acid incorporation into protein. J. bioI. Chem. 210, 837–849 (1954)
Rarinovltz, M., Mcgrath, H.: Protein synthesis by rabbit reticulocytes. II. Interruption of the pathway of hemoglobin synthesis by a valine analogue. J. bioI. Chem. 234, 2091–2095 (1959)
Ragland, J.B., Kinross-Wright, J., Ragland, R.S.: Determination of phenothiazines in biological samples. Analyt. Biochem. 12, 60–69 (1965)
Ready, D., Minarn, C.E.: New growth regulating compounds. IV. Selected toloxyacetic acids. Weeds III, 279–281 (1954)
Rehder, K., Forbes, J., Alter, H., Hessler, O., STIER, A.: Halothane biotransformation in man: A quantitative study. Anesthesiology 28,711–715 (1967)
Rennert, O.M., Anker, H.S.: Effect of 5’,5’,5’ -trifluoroleucine on a number of mouse leukemias. Nature (Lond.) 203, 1256–1257 (1964)
Renson, J., Bourdon, V.: Hydroxylation et defluorination des derives fluores de l’aniline. Arch. into Pharmacodyn. 171, 240–242 (1968)
Richmond, M. H.: Immunological properties of exopenicillinase synthesized by Bacillus cereus 569fH in the presence of amino acid analogues. Biochem. J. 77, 112–121 (1960a)
Richmond, M. H.: Incorporation of DL-P-(p-fluorophenyl)[p-14C]alanine into exopenicillinase by Bacillus cereus 569JH. Biochem. J. 77, 121–135 (1960b)
Richmond, M. H.: The effect of amino acid analogues on growth and protein synthesis in microorganisms. Bact. Rev. 26, 398–420 (1962a)
Richmond, M. H.: The incorporation of p-fluorophenylalanine into alkaline phosphatase of Escherichia coli. Biochem. J. 84, 110P–111P (1962b)
Richter, D.: Mode of action of the phenothiazines. In: The Scientific Basis of Drug Therapy in Psychiatry. Proceedings of a symposium at St. Bartholomew’s Hospital, London, Sept. 7th and 8th, 1965, pp. 63–69 (1964)
Roberts, J.D., Webb, R.L., Mcelhill, E.A.: The electrical effect of the trifluoromethyl group. J. Amer. chem. Soc. 72, 408–411 (1950)
Robertson, J.E., Dusterhoft, D.A., Mitchell, T.F., Jr.: Diuretics. 6-Substituted 3-ketoalkyl-3,4-dihydro-2H-l,2–4-benzothiadiazine 1,1-dioxides and related anils, oximes and hydrazones. J. med. Chem. 8, 90–95 (1965)
Robinson, A. E.: Biotransformations in vitro undergone by phenothiazine derivatives in a liver preparation. J. Pharm. Pharmacol. 18, 19–32 (1966)
Robinson, C.H., Bruce, N.F., Oliveto, E.P., Tolksdorf, S., Steinberg, M., Perlman, P.L.: 16,16-Difluoroestrone derivatives. A new series of cholesterol lowering agents. J. Amer. chem. Soc. 82, 5256 (1960)
Robson, J.M., Stacey, R.S.: Psychotropic drugs. In: Recent Advances in Pharmacology, Chapter 2, pp. 42–94. London: J.A. Churchill Ltd. 1962
Roediger, P.M., Alden, J., Bearwood, D., Hutcmson, J.C.: Benzothiadiazines and diabetes mellitus. II. Comparison of hyperglycemic effects ofbendroflumethiazide and chlorothiazide in hypertensive patients with diabetes mellitus. Curro ther. Res. 6,670–676 (1964)
Ross, C.R., Cafruny, E.J.: Blockade of the diuretic action ofbenzothiadiazines. J. Pharmacol. expo Ther. 140, 125–132 (1963)
Roth, B., Falco, E.A., Hitchings, G.H.: 5-Benzyl-2,4-diaminopyrimidines as antibacterial agents. I. Synthesis and antibacterial activity in vitro. J. med. pharm. Chem. 5, 1103–1123 (1962)
Schumann, E.L., Greig, M.E., Heinzelman, R. V., Jeay, P.H.: The synthesis and pharmacological actions of ortho-substituted phenethylhydrazines. J. med. pharm. Chem. 3, 567–582 (1961)
Schweet, R.S., Allen, E.H.: Purification and properties of tyrosine-activating enzyme of hog pancreas. J. biol. Chem. 233, 1104–1108 (1958)
Scott, G. T., Nading, L. K.: Relative effectiveness of phenothiazine tranquilizing drugs causing release of MSH. Proc. Soc. expo BioI. Med. (N.Y.) 106,88–90 (1961)
Scriabine, A., Korol, B., Kondratas, B., Yu, M., P’an, S.Y., Schneider, J.A.: Pharmacological studies with polythiazide, a new diuretic and antihypertensive agent. Proc. Soe. expo BioI. Med. (N.Y.) 107, 864–872 (1961)
Scriabine, A., Schremer, E.C., Yu, M., Wiseman, E.H.: Renal clearance of polythiazide. Proe. Soc. expo BioI. Med. (N.Y.) 110, 872–875 (1962)
Seeman, P., Weinstein, J.: I. Erythrocyte membrane stabilization by tranquilizers and antihistamines. Biochem. Pharmacol. 15,1737–1752 (1966)
Seeman, P.M., Bialy: The surface activity of tranquilizers. Biochem. Pharmacol. 12,1181–1191 (1963)
Seidel, J.C., Harper, A.E.: Diet and cholesterolemia. VII. Effects of methionine, ethionine, andp-fluorophenylalanine. J. Lipid Res. 4, 75–80 (1963)
Selenkow, H.A., Asper, S.P.: Biological activity of compounds structurally related to thyroxine. Physiol. Rev. 35, 426–474 (1955)
Shapiro, A.P., Benedek, T.G., Small, J.L.: Effect ofthiazides on carbohydrate metabolism in patients with hypertension. New Engl. J. Med. 265, 1028–1033 (1961)
Sharon, N., Lipmann, F.: Reactivity of analogs with pancreatic tryptophan-activating enzyme. Arch. Biochem. 69, 219–227 (1957)
Sheppard, H., Mowles, T.F., Bowen, N., Renzi, A.A., Plummer, A.J.: Distribution and fate of hydrochlorothiazide-H3. Toxicol. appl. Pharmacol. 2, 188–194 (1960)
Short, J.A., Biermacher, U.: Sympathetic nervous system blocking agents. Investigation of ethyl-, hydroxyethyl-, vinyloxyethyl-, and propargyl-benzyldimethylammonium halides and related compounds. J. pharm. Sci. 51, 881–884 (1962)
Short, J.A., Biermacher, U., Dunnigan, D.A., Lambert, G.F., Martin, D.L., Nordeen, C.W., Wright, H.B.: Hypocholestermic agents. III. Basic carbinols and related compounds. J. med. Chem.,7, 223–230 (1965)
Simons, J.H.: Fluorine Chemistry, vol. I, p. 402. J.H. Simons (Ed.). New York, N.Y.: Academic Press Inc. 1950
Simpson G.M., Cooper, T.B.: The effect of three butyrophenones on serum cholesterol levels. Curro ther. Res. 8,249–255 (1966)
Sliiall, A.M., Krssllian, H.M., Joseph, J.P., WEISS, M.J.: The synthesis of certain 9-(3-acylamino-3-deoxy-p-D-ribofuranosyl)-6-dimethylaminopurines, analogues of the antibiotic puromycin. J. med. pharm. Chem. 2, 375–389 (1960)
Smith, A., Tranter, E. K., Cain, R. B.: The utilization of some halogenated aromatic acids by Nocardia. Effects on growth and enzyme induction. Biochem. J. 106, 203–209 (1968)
Smith, C.I., Burke, J.C.: Enzymatic hydrolysis of acetylfluphenazine to fluphenazine by certain mammalian tissues in vitro. Toxicol. appl. Pharmacol. 2, 553–557 (1960)
Smith, C.I., Sohlosser, A.: Procedure for the estimation of Vesprin in biological fluids. Some results from its application in studies of the metabolism of Vesprin. Monogr. on Ther. 3, 41–44 (1958)
Smith, R. L., Maickel, R. P., Brodie, B. B.: ACTH-Hypersecretion induced by phenothiazine tranquilizers. J. Pharmacol. expo Ther. 139, 185–190 (1963)
Sollia, L.R., smelds, D.R.: Neuroleptanalgesia produced by fentanyl and droperidol. J. Amer. vet. med. Ass. 145,897–902 (1964)
Soper, Q.F., Whitehead, C.W., Behrens, O.K., Corse, J.J., Jones, R.G.: Biosynthesis of penicillins. VII. Oxy- and mercaptoacetic acids. J. Amer. chem. Soc. 70, 2849–2855 (1948)
Soudun, W., Van Wungaarden, I., Allewijn, F.: Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. Part. I. Excretion and metabolism of haloperidol and nine related butyrophenone-derivatives in the Wistar rat. Europ. J. Pharmacol. 1, 47–57 (1967)
Spencer, R.P., Brock, D.: Transamination and deamination of halogenated aromatic amino acids. Endocrinology 70, 750–751 (1962)
Sprague, J.M.: Some results of molecular modifications of diuretics. In: R.F. Gould (Ed.), Molecular Modification of Drug Design, Advances in Chemistry Series 45, pp. 87–101.Washington, D.C.: American Chemical Society 1964
Stefanye, D., Derose, H.R.: Comparative herbicidal activities of carbamates and N-substituted derivatives. Agr. Food Chem. 7, 425–427 (1959)
Stier, A.: Trifl.uoroacetic acid as metabolite of halothane. Biochem. Pharmacol. 13”. 1544 (1964)
Stier, A., Alter, H., Hessler, O., Rehder, K.: Urinary excretion of bromide in halothane anesthesia. Anesth. Analges. 43, 723–728 (1964)
Sullivan, L.P., Pirch, J.H.: Effect ofbendroflumethiazide on distal nephron transport of sodium, potassium and chloride. J. Pharmacol. expo Ther. 151, 168–179 (1966)
Summerly, R., Yardley, H. J.: The effect of a substituted fluorobutyrophenone (Haloperidol) on the metabolism of sterols in rat skin. Biochem. J. 96, 30P (1965)
Suter, C. M., Weston, A. W.: Some fluorinated amines ofthe pressor type. J. Amer. chem. Soc. 63, 602–605 (1941)
Sveinbjornsson, A., Vander Werf, C.A.: Some fluorine-containing isosteres of sulfa drugs. J. Amer. chem. Soc. 73, 869–870 (1951)
Symchowicz, S., Peckhalii, W.D., Eisler, M., Perlliian, P.L.: The distribution and excretion of radioactivity after administration of 35S-labeled perphenazine (Trilafon). Biochem. Pharmacol. 11, 417–422 (1962)
Taborsky, R.G., Starkey, R.J.: Substituted salicylanilides. II. Further antimicrobial and other studies with halonitrosalicylanilides. J. pharm. Sci. 51, 1152–1155 (1962)
Takeda, A.: m-Nitro- and m-trifl.uoromethylaryl acids as plant growth regulators. Contrib. Boyce Thompson Inst. 20, 191–196 (1959)
Tange, J. D., Newman, R. G.: Arterial lesions in rats following injection of 4’ -fluoro-10-methyl- 1,2-benzanthracene. Amer. J. Path. 43, 897–911 (1963)
Taylor, R.M., Topliss, J. G.: Structure-activity relationships of 3-substituted dihydrobenzothiadiazine diuretics. J. med. pharm. Chem. 5, 312–320 (1962)
Tedeschi, D.H., Spencer, J.N., Macko, E., Tedeschi, R.E., Leonard, C.A., Mclean, R.A., Flanagan, T., Cook, L., Mattis, P.A., Fellows, E.J.: Psychopharmacology, pharmacology and chemistry. In: Trifluoperazine, Clinical and Pharmacological Aspects. Philadelphia: Lea and Febiger 1958
Tedeschi, D.H., Tedeschi, R.E., Cook, L., Mattis, P.A., Fellows, E.J.: The neuropharmacology of trifluoperazine: a potent psychotherapeutic agent. Arch. into Pharmacodyn. 122, 129–143 (1959b)
Tedeschi, D.H., Tedeschi, R.E., Fellows, E.J.: Central serotonin antagonist activity of a number of phenothiazines. Arch. into Pharmacodyn. 132, 172–179 (1961)
Tedeschi, R.E., Tedeschi, D.H., Cook, L., Mattis, P.A., Fellows, E.J.: some neuropharmacological observations on SKF trans 385 (2-phenylcyclopropylamine hydrochloride), a potent inhibitor of monoamine oxidase. Fed. Proc. 18, 451 (1959a)
Tehon, L.R.: Fungistatic potencies of some fluorinated p-benzoquinones. Science 114, 663–664 (1951)
Thayer, J.D., Seligman, B.B.: The antituberculous activity of some derivatives of p-aminosalicylic acid, nicotinic acid, and isonicotinic acid. Antibiot. and Chemother. 3, 129–131 (1955)
Thompson, P.E., Reinertson, J.W., Bayles, A., Mccarthy, D.A., Elslager, E.F.: Antiamebic action of 5-chloro-7-diethylaminomethyl-8-quinolinol and other substituted 8-quinolinols in vitro and in experimental animals. Amer. J. trop. Med. Hyg. 4, 224–248 (1955)
Tomcufcik, A.S., Seeger, D.R.: The synthesis of the 3’-fluoro and 3’-5’-difluoro derivatives of 4-amino-4-deoxy-Nlo-methylpteroylglutamic acid (methotrexate). J. org. Chem. 26, 3351–3356 (1961)
Tonomura, K., Futai, F., Tanabe, O., Yamaoka, T.: Defluorination of monofluoroacetate by bacteria. Part I. Isolation of bacteria and their activity of defluorination. Agr. biol. Chem. (Tokyo) 29, 124–128 (1965)
Topliss, J.G., Konzelman, L.M., Shapiro, E.P., Sperber, N., Roth, F.E.: Antihypertensive agents. II. 3-Substituted 2H-1,2,4-benzothiadiazine 1,1-dioxides. J. med. Chem. 7, 269–273 (1964b)
Topliss, J.G., Konzelman, L.M., Sperber, N., Roth, F.E.: Antihypertensive agents. III. 3-Hydroxy-3-phenylphthalimidines. J. med. Chem. 7, 453–456 (l964a)
Topliss, J.G., Sherlock, M.H., Reimann, H., Konzelman, L.M., Shapiro, E.P., Pettersen, B.W., Schneider, H., Sperber, N.: Antihypertensive agents. I. Non-diuretic 2H-1,2,4-benzothiadiazine 1,1-dioxides. J. med. Chem. 6, 122–127 (1963)
Traub, A., Ginzburg, Y.: The response of glycolytic and non-glycolytic mammalian cells to the inhibitory action offluoro-pyruvate. Exp. Cell Res. 17, 246–255 (1959)
Truggle, D.J.: The reaction mechanisms, selectivity and specificity of action 2-halogenoethylamines. An analysis. J. theor. Biol. 7, 241–275 (1964)
Tweit, R. C., Muir, R. D., Mrzuba, S., Crowley, W. R., JR.: Antifungal activity of a series of Bubstituted [(a-nitroalkyl) benzylthio] alkylamines. J. med. Chem. 8, 374–377 (1965)
Ulloyt, G.E., Kerwin, J.F.: p-Haloethylamine adrenergic blocking agents: chemistry and structure-activity relationships. In: F.F. Blicke and C.M. Suter (Eds.), Medicinal Chemistry, vol. II, pp. 234–307. New York: John Wiley and Sons Inc. 1956
Ullrich, V., Wolf, J., Amradori, E., Staudinger, H.: The mixed function oxygenation of 4-halogenoacetanilides in rat liver microsomes and model systems. Hoppe-Seylers Z. physiol. Chem. 349, 85–94 (1968)
Vanbreuseghem, R., Buu-Hoï’, N.P., Xuong, N.D., Lamibelin, G.: Activite fongistatique, pharmacodynamique et therapeutique du 3:5-dichloro-4’-fluorothiocarbanilide. Biochem. Pharmacol. 11, 813–822 (1962)
Van Dyke, R. A.: Metabolism of volatile anesthetics. III. Induction of microsomal dechlorinating and ether-cleaving enzymes. J. Pharmacol. expo Ther. 154,364–369 (1966)
Van Dyke, R. A., Chenoweth, M.B.: Metabolism of volatile anesthetics. A review. Anesthesiology 26, 348–357 (1965a)
Van Dyke, R. A. The metabolism of volatile anesthetics. II. In vitro metabolisms of methoxyflurane and halothane in rat liver slices and cell fractions. Biochem. Pharmacol. 14,603–609 (1965b)
Van Dyke, R. A., Van Dyke, R. A., Larsen, E.R.: Synthesis and metabolism of halothane-1-HC. Nature (Lond.) 204, 471–472 (1964a)
Van Dyke, R. A., Van Dyke, R. A., Poznak, A. V.: Metabolism of volatile anesthetics. I. Conversion in vivo of several anesthetics to 14C02 and chloride. Biochem. Pharmacol. 13, 1239–1247 (1964b)
van Loon, E.J., Flanagan, T.L., Novick, W.J., Maass, A.R.: Hepatic secretion and urinary excretion of three sao-labeled phenothiazines in the dog. J. pharm. Sci. 53, 1211–1213 (1964)
Van De Westeringh, C., Van Daele, P., Hermans, B., Van Der Eycken, C.: 4-Substituted piperidines. I. Derivatives of 4-t-amino-4-piperidinecarboxamides. J. med. pharm. Chem. 1, 619–623 (1964)
Vaughan, M., Steinberg, D.: Advances in Protein Chemistry, vol. XIV, p. 157. C.B. Anfinsen, Jr., M.L. Anson, K. Bailey, and J.T. Edsall (Eds.). New York: Academic Press 1959
Vaughan, M., Steinberg, D.,Biosynthetic incorporation of fluorophenylalanine in crystalline proteins. Biochim. biophys. Acta (Amst.) 40, 230–236 (1960)
Vogel, A.W.: Tumor and marrow damage occurring from methotrexate, monofluoromethotrexate, difluoromethotrexate, and dichloromethotrexate. Cancer Res. 21, 743–748 (1961)
Waddington, C. H., Perry, M.: Effects of some amino-acid and purine antagonists on chick embryos. J. Embryol. expo Morph. 6, 365–372 (1958)
Walborsky, H.M., Baum, M., Loncrini, D.F.: The synthesis of m-trifluoromethyl amino acids. II. Their microbiological activities. J. Amer. chem. Soc. 77, 3637–3640 (1955)
Walborsky, H.M., Lang, J.H.: Effects of the trifluoromethyl group. IV. The pK’s of m-trifluoromethyl amino acids. J. Amer. chem. Soc. 78, 4314–4316 (1956)
Ward, P.F.V., Hall, RJ., Peters, R.A.: Fluoro-fatty acids in the seeds of Dichapetalum toxicarium. Nature (Lond.) 201, 611–612 (1964)
Wechsler, M.B., Roizin, L.: Tissue levels of chlorpromazine in experimental animals. J. ment. Sci. 106, 1501–1505 (1960)
Weil-Malherbe, H., Posner, H. S.: The effect of drugs on the release of epinephrine from adrenomedullary particles in vitro. J. Pharmacol. expo Ther. 140, 93–102 (1963)
Weil-Malherbe, H., Posner, H. S. The biphasic effect of phenothiazines and reserpine on the release of epinephrine from adrenomedullary granules and its dependence on pH. Biochem. Pharmacol. 13, 685–690 (1964)
Weintraub, R.L., Brown, J.W., Throne, J.A.: Relation between molecular structure and physiological activity of plant-growth regulators. II. Formative activity of phenoxyacetic acids. J. Agr. Food Chem. 2, 996–999 (1954)
Weissman, A., Koe, B. K.: Studies on the mechanism of convulsant action of DL-m-fluorotyrosine. Pharmacologist 8, 215 (1966)
Weissman, A., Koe, B. K. m-Fluorotyrosine convulsions and mortality: relationship to catecholamine and citrate metabolism. J. Pharmacol. expo Ther. 155, 135–144 (1967)
Westhead, E. W., Boyer, P. D.: The incorporation of p-fluorophenylalanine into some rabbit enzymes and other proteins. Biochim. biophys. Acta (Amst.) 54, 145–156 (1961)
Westrop, J.W., Topham, J.C.: Defluorination and hydroxylation of 4’-fluoro-4-dimethylaminoazobenzene by rat liver in vivo and its possible relevance to mechanisms of chemical carcinogenesis. Nature (Lond.) 210, 712–714 (1966)
Wilde, C.E., Jr.: The role of phenylalanine in the differentiation of neural crest cells. Ann. N.Y. Acad. Sci. 60, 1015–1025 (1954–1955)
Wiley, R.H., Clevenger, R.L.: Aldehyde hydrazone derivatives in cancer chemotherapy. J. med. pharm. Chem. 5, 1367–1371 (1962)
Williams, R T.: Detoxication Mechanisms, 2nd edition, p. 357. New York, N.Y.: Wiley and Sons Inc. 1959a
Williams, R T. Ibid., p. 155, 1959b
Williams, R T. Ibid., p. 238, 1959c
Williams, R T. Ibid., p. 250, 1959d
Winnick, T., Winnick, R. E., Bergmann, E. D.: Some metabolic and enzymic experiments with a-fluoro-.B-alanine. Biochim. biophys. Acta (Amst.) 69,48–58 (1963)
Wiseman, E.H., Perema, J.N., Finger, K.F., Pinson, R., JR.: Sulfamylurea hypoglycemic agents. II. Drug dynamic studies. J. med. Chem. 8, 777–781 (1965)
Woakes, E.: The pathogeny and treatment of bronchocele or goiter. Lancet 1881 1,448–450; 497–498; 537–538
Wozniak, L.A., Taino, A., Ringler, I., Roepke, RR: A study of the diuretic effect oftriamcinolone in the dog. J. Pharmacol. expo Ther. 129,82–88 (1960)
Wright, J.B., Dulin, W.E., Markillie, J.H.: The antidiabetic activity of 3,5-dimethylpyrazoles. J. med. Chem. 7, 102–105 (1964)
Wyant, G.M.: A comparative study of eleven anti-emetic drugs in dogs. Canad. Anaesth. Soc. J. 9, 399–407 (1962)
Yale, H. L., Cohen, A. I., Sowinski, F.: Esters of 4-(-[2-(trifluoromethyl)phenothiazin-l0-yl] propyl)-I-piperazineethanolethyl-C14 and its ester with heptanoic acid. III. J. med. Chem. 6, 347–350 (1963)
Yelnosky, J., Field, W. E.: A preliminary report on the use of a combination of droperidol and fentanyl citrate in veterinary medicine. Amer. J. vet. Res. 25,1751–1756 (1964)
Yelnosky, J., Gardocki, J.F.: A study of some of the pharmacologic actions of fentanyl citrate and droperidol. Toxicol. appl. Pharmacol. 6, 63–70 (1964)
Yelnosky, J., Katz, R., Dietrich, E. V.: A study of some of the pharmacologic actions of droperidol. Toxicol. appl. Pharmacol. 6, 37–47 (1964)
Young, L., Zbarsky, S.H.: Mercapturic acids. V. The metabolic formation ofp-fiuorophenylmercapturic acid from fiuorobenzene. J. bioI. Chem. 154, 389–395 (1944)
Youngdale, G.A., Anger, D.A., Anthony, W.C., Davanzo, J.P., Greig, M.A., Heinzelman, R. V., Keasling, H. H., Szmuszkovicz, J.: Synthesis and pharmacological activity of 3-(2-pyrrolidinyl)indoles. J. med. Chem. 7, 415–427 (1964)
Zeller, E.A., Barsky, J.: in vivo Inhibition of liver and brain monoamine oxidase by l-isonicotinyl-2-isopropyl hydrazine. Proc. Soc. expo Biol. Med. (N.Y.) 81, 459–461 (1952)
Zirkle, C.L., Kaiser, C., Tedescm, D.H., Tedescm, R.E., Burger, A.: 2-Substituted cyclopropylamines. II. Effect of structure upon monoamine oxidase-inhibitory activity as measured in vivo by potentiation of tryptamine convulsions. J. med. pharm. Chem. 5, 1265–1284 (1962)
Zuber, F., Sorkin, E., Erlenmeyer, H.: Vber vergleichende Untersuchungen mit NH2- und F-Verbindungen. Helv. chilli. Acta 33, 1269 –1271 (1950)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1970 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Smith, F.A. (1970). Biological Properties of Selected Fluorine-Containing Organic Compounds. In: Smith, F.A. (eds) Pharmacology of Fluorides. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 20 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-99973-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-99973-4_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-99975-8
Online ISBN: 978-3-642-99973-4
eBook Packages: Springer Book Archive